Literature DB >> 2063763

Evaluation of restenosis after balloon dilatation in adult aortic stenosis by repeat catheterization.

B Letac1, A Cribier, H Eltchaninoff, R Koning, G Derumeaux.   

Abstract

To evaluate the restenosis rate after successful balloon aortic valvuloplasty, clinical evaluation and repeat catheterization were performed in 96 patients who had undergone balloon dilatation 7 +/- 5 months earlier. Restenosis, defined as a loss of greater than 50% of the benefit in aortic valve area obtained after balloon valvuloplasty, was observed in 48% of the patients. Actuarial analysis showed that the restenosis rate was time dependent and was 80% at 15 months. However, functional improvement was observed in most of the patients with or without restenosis. The restenosis rate was not correlated with the degree of enlargement of the aortic orifice produced by the valvuloplasty procedure. Because of the high incidence of restenosis, balloon aortic valvuloplasty should be limited to patients who have a contraindication to surgery or are at high risk for surgery, or as a bridge to surgery.

Entities:  

Mesh:

Year:  1991        PMID: 2063763     DOI: 10.1016/0002-8703(91)90758-a

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

Review 1.  Advances in transcatheter valve therapies.

Authors:  Daniel H Steinberg; Mario Castillo-Sang; Eric R Powers
Journal:  J Cardiovasc Transl Res       Date:  2014-04-10       Impact factor: 4.132

2.  Vascular complications and bleeding after balloon aortic valvuloplasty performed with or without heparin: HEPAVALVE randomized study.

Authors:  Mariama Akodad; Jessica Labour; Erika Nogue; Delphine Delseny; Jean-Christophe Macia; Richard Gervasoni; Benoit Lattuca; Nicolas Nagot; François Roubille; Guillaume Cayla; Florence Leclercq
Journal:  Int J Cardiol Heart Vasc       Date:  2022-01-18

Review 3.  Patient survival in severe low-flow, low-gradient aortic stenosis after aortic valve replacement or conservative management.

Authors:  Linda R Micali; Salma Algargoosh; Orlando Parise; Gianmarco Parise; Francesco Matteucci; Monique de Jong; Amalia Ioanna Moula; Cecilia Tetta; Sandro Gelsomino
Journal:  J Card Surg       Date:  2020-12-18       Impact factor: 1.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.